Sick India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.50 M
as on 18-07-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.37 M
as on 18-07-2024
- Revenue 20.21%
(FY 2023)
- Profit 6.73%
(FY 2023)
- Ebitda 0.10%
(FY 2023)
- Net Worth 29.08%
(FY 2023)
- Total Assets 39.49%
(FY 2023)
About Sick India
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹0.37 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Atul Dave, Klaus Brack, and Ulrike Roth serve as directors at the Company.
- CIN/LLPIN
U32109MH2005PTC192559
- Company No.
192559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2005
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sick India Private Limited offer?
Sick India Private Limited offers a wide range of products and services, including Analyzers & Analytical Instruments, Gas Analyzers, Sensors & Transducers, Position Sensor, Level Sensors, Proximity Switches, Displacement Sensors, Surveillance Systems, CCTV System, Distance Measuring Sensors.
Who are the key members and board of directors at Sick India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Dave  | Director | 20-Jun-2014 | Current |
Klaus Brack  | Director | 16-Feb-2021 | Current |
| Ulrike Roth | Director | 27-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Sick India.
Sick India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.21% increase. The company also saw a slight improvement in profitability, with a 6.73% increase in profit. The company's net worth Soared by an impressive increase of 29.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sick India?
In 2023, Sick India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 13 Apr 2016 | ₹0.37 M | Satisfied |
How Many Employees Work at Sick India?
Sick India has a workforce of 135 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sick India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sick India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
